Functional gait assessment in patients with relapsing-remitting Multiple Sclerosis and relation to the risk of falls

Authors

  • Bruno Moraes UFF
  • Marco Orsini UNISUAM
  • Rossano Fiorelli USS
  • Victor Marinho UFPI
  • Silmar Teixeira UFPI
  • Victor Hugo Bastos UFPI
  • André Matta UFF

DOI:

https://doi.org/10.33233/fb.v19i2.2302

Abstract

Objetivo: Demonstrar as avaliações funcionais e sua correlação nos padrões de marcha de pacientes com Esclerose Múltipla, utilizando um método não invasivo por meio do Timed Up and Go, teste de Tinetti, teste de caminhada de 25 pés e escala de Expanded Disability Status Scale (EDSS). Métodos: Foram avaliados 40 pacientes com Esclerose Múltipla, usando Timed Up and Go, teste de Tinetti, teste de caminhada de 25 pés e escala de EDSS. Resultados: No presente estudo, observamos correlações moderadas a altas entre EDSS e Timed Up and Go, teste de Tinetti e teste de caminhada de 25 pés (p < 0,0001). Os pacientes relataram tempos de execução mais longos para os testes Timed Up and Go e 25-Foot Walk e menores escores no teste de Tinetti. Encontramos uma correlação direta entre a duração da doença, a escala EDSS, o tempo de execução Timed Up and Go, o tempo de execução de 25-Foot Walk e o escore do teste de Tinetti (p < 0,0001). Conclusão: avaliações adequadas de risco de marcha e queda são importantes para evitar complicações relacionadas í  Esclerose Múltipla.

Palavras-chave: esclerose múltipla, avaliação da marcha, EDSS, risco de quedas.

 

Author Biographies

Bruno Moraes, UFF

Neurology Service, Federal Fluminense University, University Hospital Antônio Pedro, Niterói/RJ

Marco Orsini, UNISUAM

Rehabilitation Science Program, Analysis of Human Movement Laboratory, Augusto Motta University Center (UNISUAM), Rio de Janeiro, Master's Program in Health Applied Sciences – USS, Vassouras, Rio de Janeiro

Rossano Fiorelli, USS

Master's Program in Health Applied Sciences – USS, Vassouras, Rio de Janeiro

Victor Marinho, UFPI

Brain Mapping and Plasticity Laboratory, Federal University of Piauí­ (UFPI), Parnaí­ba/PI

Silmar Teixeira, UFPI

Brain Mapping and Plasticity Laboratory, Federal University of Piauí­ (UFPI), Parnaí­ba/PI

Victor Hugo Bastos, UFPI

Brain Mapping and Plasticity Laboratory, Federal University of Piauí­ (UFPI), Parnaí­ba/PI

André Matta, UFF

Neurology Service, Federal Fluminense University, University Hospital Antônio Pedro, Niterói, Rio de Janeiro

References

Bethoux F. Gait disorders in multiple sclerosis. Continuum (Minneap Minn) 2013;19:1007-22.

Behm K, Morgan P. The effect of symptom-controlling medication on gait outcomes in people with multiple sclerosis: a systematic review. Disabil Rehabil 2017;4:1-12.

Kelleher KJ, Spence W, Solomonidis S et al. The characterization of gait patterns of people with multiple sclerosis. Disabil Rehabil 2010; 32:1242-50.

Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 2014;83:278-86.

Monticone M, Ambrosini E, Fiorentini R, Rocca B, Liquori V, Pedrocchi A, Ferrante S. Reliability of spatial-temporal gait parameters during dual-task interference in people with multiple sclerosis. A cross-sectional study. Gait Posture 2014;40:715-8.

Sosnoff J, Molt R, Morrison S.: Multiple sclerosis and falls - an evolving tale: US Neurology 2013; 9(1):30-4

Bethoux F, Bennett S. Evaluating walking in patients with multiple sclerosis. which assessment tools are useful in clinical practice? Int J MS Care 2011;13:4-14.

Kalron A, Dvir Z, Achiron A. Walking while talking-Difficulties incurred during the initial stages of multiple sclerosis disease process. Gait Posture 2010;32:332-5.

Galea MP, Cofré Lizama LE, Butzkueven H, Kilpatrick TJ. Gait and balance deterioration over a 12-month period in multiple sclerosis patients with EDSS scores ≤ 3.0. NeuroRehabilitation 2017;40(2):277-84.

Newsome SD, Wang JI, Kang JY, Calabresi PA, Zackowski KM. Quantitative measures detect sensory and motor impairments in multiple sclerosis. J Neurol Sci 2011;305:103-11.

Gunn H, Creanor S, Haas B, Marsden J, Freeman J. Frequency, characteristics, and consequences of falls in multiple sclerosis: findings from a cohort study. Arch Phys Med Rehabil 2014;95(3):538-45.

Fritz NE, Jiang A, Keller J, Zackowski KM. Utility of the six-spot step test as a measure of walking performance in ambulatory individuals with multiple sclerosis. Arch Phys Med Rehabil 2016;97(4):507-12.

Lizrova Preiningerova J, Novotna K, Rusz J, Sucha L, Ruzicka E, Havrdova E. Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5). J Neuroeng Rehabil 2015;12:14.

Döring A, Pfueller CF, Paul F, Dörr J. Exercise in multiple sclerosis – an integral component of disease management. EPMA J 2011;24;3(1):2.

Yamout B, Alroughani R, Al-Jumah M, et al. Consensus guidelines for the diagnosis and treatment of multiple sclerosis. Curr Med Res Opin 2013; 29:611-21.

Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69(2):292-302.

NeamŢu MC, NeamŢu OM, Marin MI, Enescu Bieru D, Rusu L. Prediction of motor disorders in multiple sclerosis using muscle change structure assessment. Rom J Morphol Embryol 2016;57(4):1331-5.

Dujmovic I, Radovanovic S, Martinovic V, Dackovic J, Maric G, Mesaros S, Pekmezovic T, Kostic V, Drulovic J. Gait pattern in patients with different multiple sclerosis phenotypes. Mult Scler Relat Disord 2017;13:13-20.

Samaei A, Bakhtiary AH, Hajihasani A, Fatemi E, Motaharinezhad F. Uphill and downhill walking in multiple sclerosis: a randomized controlled trial. Int J MS Care 2016;18(1):34-41.

Goldman MD, Motl RW, Scagnelli J, Pula JH, Sosnoff JJ, Cadavid D. Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world. Neurology 2013; 81(21):1856-63.

Kiesseier B, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler 2012;18:914-24.

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33(11):1444-52.

Fischer JS, Jak AJ, Kniker JE, Rudick RA. Administration and scoring manual for the National Multiple Sclerosis Society; 2001.

Learmonth YC, Paul L, McFadyen AK, Mattison P, Miller L. Reliability and clinical significance of mobility and balance assessments in multiple sclerosis. Int J Rehabil Res 2012;35:69-74.

Coote S, Gallagher S, Msetfi R, Larkin A, Newell J, Motl RW, Hayes S. A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol. BMC Neurol 2014;14:241.

Shahraki M, Sohrabi M, Taheri Torbati HR, Nikkhah K, NaeimiKia M. Effect of rhythmic auditory stimulation on gait kinematic parameters of patients with multiple sclerosis. J Med Life 2017;10(1):33-7.

Nilsagård Y, Westerdahl E, Wittrin A, Gunnarsson M. Walking distance as a predictor of falls in people with multiple sclerosis. Physiother Res Int 2016;21(2):102-8.

Fjeldstad C, Pardo G. Immediate effect of a service dog on walking speed in individuals with multiple sclerosis and gait dysfunction: a pilot study. Int J MS Care 2017;19(1):40-1.

Zwibel HL. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. AdvTher 2009;26:1043-57

Mazumder R, Lambert WE, Nguyen T, Burdette DN, Cameron MH. Fear of falling is associated with recurrent falls in people with multiple sclerosis: a longitudinal cohort study. Int J MS Care 2015;17(4):164-70. doi: 10.7224/1537-2073.2014-042.

Published

2018-05-11